Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy

Jiulong Zhang1, Xiufeng Zhao2, Qing Chen3

  • 1Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, PR China.

Acta Biomaterialia
|December 14, 2016
PubMed

Insights

This study developed pH-sensitive mixed micelles loaded with paclitaxel to overcome multidrug resistance (MDR) in breast cancer. The novel system enhanced drug delivery and antitumor efficacy in resistant cells by inhibiting P-glycoprotein (P-gp).

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Research

Background:

  • Multidrug resistance (MDR) in tumor cells, primarily mediated by P-glycoprotein (P-gp) efflux, is a major cause of chemotherapy failure.
  • Developing effective drug delivery systems is crucial to overcome MDR and improve cancer treatment outcomes.

Purpose of the Study:

  • To design and evaluate a novel pH-responsive mixed micelle system (FA-TPGS2K/HDP) for delivering paclitaxel (PTX) to P-gp-mediated MDR breast cancer cells (MCF-7/PTX).
  • To investigate the synergistic effects of folate receptor-mediated endocytosis, pH-responsive drug release, and P-gp inhibition by the developed micelles.

Main Methods:

  • Synthesis of FA-TPGS2K copolymer and its combination with HDP copolymer to form mixed micelles loaded with PTX.
  • Characterization of mixed micelles for size, drug loading, and pH-responsive release.
  • In vitro evaluation of cytotoxicity, P-gp activity inhibition (ATP content, mitochondrial membrane potential), and cellular uptake in MCF-7 and MCF-7/PTX cells.
  • In vivo antitumor efficacy studies and histological analysis (apoptosis, proliferation, angiogenesis) in tumor-bearing mice.

Main Results:

  • PTX-loaded FA-TPGS2K/HDP mixed micelles exhibited small size, high drug loading, and excellent pH-responsive release.
  • FA-TPGS2K/HDP mixed micelles demonstrated superior cytotoxicity against MCF-7/PTX cells compared to HDP micelles.
  • Blank FA-TPGS2K/HDP micelles inhibited P-gp activity by affecting mitochondrial membrane potential and ATP levels without altering P-gp expression.
  • In vivo studies showed enhanced antitumor activity, apoptosis, anti-proliferation, and anti-angiogenesis effects of FA-TPGS2K/HDP mixed micelles.

Conclusions:

  • The pH-sensitive FA-TPGS2K/HDP mixed micelle system effectively delivers PTX to MDR breast cancer cells.
  • This novel drug delivery system shows significant potential in overcoming P-gp-mediated multidrug resistance and enhancing chemotherapy efficacy.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
71
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K